1.888.443.3311
Reduce your patient’s anxiety with test results available in days… not weeks. Clarient’s InsightDx Mammostrat provides important information independent of proliferation and grade to aid physicians in making appropriate and earlier treatment decisions in order to determine which patients are most likely to recur from breast cancer. Learn more
The FDA approved ALK Break Apart FISH Probe Kit for metastatic NSCLC.
The FDA approved cobas® 4800 test for metastatic Melanoma. Learn more
Clarient Continuum is an educational event that demonstrates our commitment to continuing education. We invite you to hear specialists, gain insights, and learn about innovations in the industry. If you missed the latest webinars, please click here.